These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 22947194)
1. Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy. Stewart PA; Phillips S; De Boer HD Rev Esp Anestesiol Reanim; 2013 Apr; 60(4):226-9. PubMed ID: 22947194 [TBL] [Abstract][Full Text] [Related]
2. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. de Boer HD; van Esmond J; Booij LH; Driessen JJ Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737 [TBL] [Abstract][Full Text] [Related]
3. Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study. Pavoni V; Gianesello L; De Scisciolo G; Provvedi E; Horton D; Barbagli R; Conti P; Conti R; Giunta F Minerva Anestesiol; 2012 May; 78(5):542-9. PubMed ID: 22298182 [TBL] [Abstract][Full Text] [Related]
4. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report. Kim JE; Chun HR Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578 [TBL] [Abstract][Full Text] [Related]
5. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472 [TBL] [Abstract][Full Text] [Related]
6. Anesthesia for laparoscopic surgery in a patient with myotonic dystrophy (Steinert's disease): beneficial use of sugammadex, but incorrect use of pethidine: a case report. Mavridou P; Dimitriou V; Margaritis A; Manataki A Acta Anaesthesiol Belg; 2011; 62(2):101-4. PubMed ID: 21919378 [TBL] [Abstract][Full Text] [Related]
7. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Abrishami A; Ho J; Wong J; Yin L; Chung F Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160 [TBL] [Abstract][Full Text] [Related]
8. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334 [TBL] [Abstract][Full Text] [Related]
9. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567 [TBL] [Abstract][Full Text] [Related]
10. The effect of rocuronium and sugammadex on neuromuscular blockade in a child with congenital myotonic dystrophy type 1. Pickard A; Lobo C; Stoddart PA Paediatr Anaesth; 2013 Sep; 23(9):871-3. PubMed ID: 23763618 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade. Schaller SJ; Lewald H Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265 [TBL] [Abstract][Full Text] [Related]
12. Neuromuscular transmission: new concepts and agents. de Boer HD J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537 [TBL] [Abstract][Full Text] [Related]
13. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade. de Menezes CC; Peceguini LA; Silva ED; Simões CM Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970 [TBL] [Abstract][Full Text] [Related]
14. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex. Ren WH; Jahr JS Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969 [TBL] [Abstract][Full Text] [Related]
15. A novel approach to reversal of neuromuscular blockade. Della Rocca G; Pompei L Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157 [TBL] [Abstract][Full Text] [Related]
16. Sugammadex: a review of its use in anaesthetic practice. Yang LP; Keam SJ Drugs; 2009; 69(7):919-42. PubMed ID: 19441874 [TBL] [Abstract][Full Text] [Related]
17. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block. Hogg RM; Mirakhur RK Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771 [TBL] [Abstract][Full Text] [Related]
18. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex. de Boer HD; van Egmond J; Driessen JJ; Booij LH Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852 [TBL] [Abstract][Full Text] [Related]
19. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery. Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940 [TBL] [Abstract][Full Text] [Related]
20. Reversal of profound neuromuscular blockade with sugammadex after failure of rapid sequence endotracheal intubation: a case report. Barbosa FT; da Cunha RM Rev Bras Anestesiol; 2012; 62(2):281-4. PubMed ID: 22440384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]